Trial site
University of Texas, Southwestern
- 89running trials
- 24closed trials
The trials here
What the 114 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers10 trials
- Cystic fibrosis8 trials
- Colorectal cancer6 trials
- Pancreatic cancer6 trials
- Hearing loss5 trials
- Neuroblastoma5 trials
- Chronic kidney disease4 trials
- Head and neck cancer4 trials
- Heart failure4 trials
- Idiopathic pulmonary fibrosis4 trials
- Multiple myeloma4 trials
- Obesity4 trials
- and 57 more
- Phase
- Phase 222 trials
- Phase 314 trials
- Phase 112 trials
- Phase 1/29 trials
- Phase 2/34 trials
- Phase 44 trials
- Early phase 11 trial
- Status
- Recruiting50 trials
- Active, not recruiting31 trials
- Completed22 trials
- Not yet recruiting6 trials
- Enrolling by invitation2 trials
- Withdrawn2 trials
- Suspended1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- University of Texas Southwestern Medical Center6 trials
- Chris Goss3 trials
- Sound Pharmaceuticals, Incorporated3 trials
- University of Pennsylvania3 trials
- and 80 more
Running trials
Not yet recruiting
Recruiting
Not yet recruiting
Food As Medicine to Reduce CKD Burden in Health Disparity Populations
Not yet recruiting
Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
Recruiting
Not yet recruiting
Recruiting
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Recruiting
Recruiting
Recruiting
Recruiting
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Recruiting
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Enrolling by invitation
Recruiting
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Recruiting
Active, not recruiting
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
Recruiting
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Recruiting
Recruiting
Recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Recruiting
Recruiting
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Active, not recruiting
Recruiting
Active, not recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Recruiting
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Recruiting
Active, not recruiting
Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes
Active, not recruiting
Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
Recruiting
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Recruiting
Active, not recruiting
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
Recruiting
Active, not recruiting
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
Recruiting
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
Active, not recruiting
Active, not recruiting
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Recruiting
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
Showing 50 of 89.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers7 recruiting
- Cystic fibrosis5 recruiting
- Bladder cancer3 recruiting
- Chronic kidney disease3 recruiting
- Hearing loss3 recruiting
- Idiopathic pulmonary fibrosis3 recruiting
- Multiple myeloma3 recruiting
- Neuroblastoma3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Cervical cancer2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- COPD2 recruiting
- Endometrial cancer2 recruiting
- Follicular lymphoma2 recruiting
- Head and neck cancer2 recruiting
- Hodgkin lymphoma2 recruiting
- Mantle cell lymphoma2 recruiting
- Metastatic breast cancer2 recruiting
- Nephrotic syndrome2 recruiting
- Neurofibromatosis type 12 recruiting
- Obesity2 recruiting
- Ovarian cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Alzheimer disease1 recruiting
- Amyloidosis1 recruiting
- Autism1 recruiting
- Burkitt lymphoma1 recruiting
- Colorectal cancer1 recruiting
- Crohn's disease1 recruiting
- Cytomegalovirus infection1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Depression1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Duchenne muscular dystrophy1 recruiting
- Gaucher disease1 recruiting
- Glaucoma1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myocarditis1 recruiting
- Pancreatic cancer1 recruiting
- Peripheral artery disease1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Type 1 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Withdrawn
A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
Completed
Completed
Completed
Completed
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
Completed
Completed
A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
Recruiting
Completed
Completed
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Completed
Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial
Withdrawn
Completed
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
Completed
Completed
Reducing Disparities in the Quality of Advance Care Planning for Older Adults
Completed
Completed
Trial in Adult Participants With Spinocerebellar Ataxia (SCA)
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026